Marco H. Hofmann
机构：Boehringer Ingelheim (Germany), Boehringer Ingelheim (Austria)
发表论文 230 篇 · 总被引 2332 次 · h-index 19
代表论文
- EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway (2026 · Cancer Discovery · 被引 1)
- Albumin fusion of the rVWF fragment rD'D3 reduces internalisation by clearance receptor Stabilin-2 (2026 · Blood Cells Molecules and Diseases · 被引 1)
- Figure S8 from SOS1 Inhibition Enhances the Efficacy of KRAS<sup>G12C</sup> Inhibitors and Delays Resistance in Lung Adenocarcinoma (2026)
- Figure S4 from SOS1 Inhibition Enhances the Efficacy of KRAS<sup>G12C</sup> Inhibitors and Delays Resistance in Lung Adenocarcinoma (2026)
- Figure S18 from SOS1 Inhibition Enhances the Efficacy of KRAS<sup>G12C</sup> Inhibitors and Delays Resistance in Lung Adenocarcinoma (2026)
- Figure S2 from SOS1 Inhibition Enhances the Efficacy of KRAS<sup>G12C</sup> Inhibitors and Delays Resistance in Lung Adenocarcinoma (2026)